Skip to main content
Erschienen in: Reactions Weekly 1/2016

01.07.2016 | Case report

Thiamazole

Total myeloid aplasia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Sarker T, et al. Methimazole Induced Total Myeloid Aplasia with Delayed Recovery Despite Granulocyte Colony Stimulating Factor (G-CSF): Marrow Progenitor Recovery Kinetics. Indian Journal of Hematology and Blood Transfusion 32 (Suppl. 1): 214-218, No. 1, Jun 2016. Available from: URL: http://doi.org/10.1007/s12288-015-0595-1 - USACrossRef Sarker T, et al. Methimazole Induced Total Myeloid Aplasia with Delayed Recovery Despite Granulocyte Colony Stimulating Factor (G-CSF): Marrow Progenitor Recovery Kinetics. Indian Journal of Hematology and Blood Transfusion 32 (Suppl. 1): 214-218, No. 1, Jun 2016. Available from: URL: http://​doi.​org/​10.​1007/​s12288-015-0595-1 - USACrossRef
Metadaten
Titel
Thiamazole
Total myeloid aplasia: case report
Publikationsdatum
01.07.2016
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2016
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-016-19943-2

Weitere Artikel der Ausgabe 1/2016

Reactions Weekly 1/2016 Zur Ausgabe

Case report

Oxcarbazepine

Case report

Regorafenib